Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 3.29 M2.64 M2.68 M2.67 M2.77 M 10.76 M Research & development ————— — Operating income -7.75 M17.06 M13.29 M12.86 M-1.82 M 41.4 M Non-Operating Income, Total -24.2 M4.73 M1.35 M1.41 M-9.56 M -2.08 M Interest expense, net of interest capitalized 18.9 M21.77 M20.31 M19.6 M20.25 M 81.93 M Non-Operating Income, excl. Interest Expenses -43.11 M-17.04 M-18.96 M-18.19 M-29.81 M -84.01 M Unusual income/expense ————— — Pretax income 2.65 M30.87 M26.43 M27.25 M12 M 96.55 M Equity in earnings ————— — Taxes 000—— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 28.55 M23.72 M18.7 M27.78 M3.39 M 73.6 M Discontinued operations ————— — Net income 28.55 M23.72 M18.7 M27.78 M3.39 M 73.6 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 28.55 M23.72 M18.7 M27.78 M3.39 M 73.6 M Basic earnings per share (Basic EPS) 0.440.370.290.430.05 1.14 Diluted earnings per share (Diluted EPS) 0.440.370.290.430.05 1.14 Average basic shares outstanding 64.68 M64.87 M64.87 M64.82 M64.87 M — Diluted shares outstanding 64.68 M64.87 M64.87 M64.82 M64.87 M — EBITDA 44.56 M17.11 M13.71 M12.85 M-2.03 M 41.64 M EBIT -7.75 M17.06 M13.29 M12.86 M-1.82 M 41.4 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) -405 K50 K411 K-7 000-208 K 246 K